According to Clinuvel Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is โน6.29 Billion. In 2026 the company made a revenue of โน6.29 Billion an increase over the revenue in the year 2025 that were of โน6.04 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.